CLOCK and Duchenne muscular dystrophy: Furthermore, recent advances in bioengineering approaches, such as artificial muscle constructs or organs-on-a-chip that incorporate cell–cell communications via microfluidic technology to mimic muscle tissue ex vivo, could be applied for drug discovery efforts for clock modulators or leveraged for DMD disease modelling [181].